Adjuvanted inactivated influenza vaccine

This page covers all Adjuvanted inactivated influenza vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting H1N1 influenza virus hemagglutinin and neuraminidase antigens.

Targets

H1N1 influenza virus hemagglutinin and neuraminidase antigens

Marketed (1)

• adjuvanted Arepanrix · University of British Columbia · Immunology / Infectious Disease
  Arepanrix is an adjuvanted pandemic influenza vaccine that stimulates immune response against H1N1 influenza virus through a combination of viral antigen and an immune-enhancing adjuvant.

Phase 3 pipeline (1)

• Adjuvanted pandemic influenza candidate vaccine · GlaxoSmithKline · Immunology / Infectious Disease
  This vaccine stimulates the immune system to recognize and respond to pandemic influenza virus antigens, with an adjuvant component to enhance the immune response.